Alnylam Pharmaceuticals
ALNY
#634
Rank
NZ$54.54 B
Marketcap
$422.92
Share price
-0.80%
Change (1 day)
56.43%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company